Skip to main content
Equibles

ADAR1 Capital Management, LLC

Position in MLTX — MoonLake Immunotherapeutics

CIK 1940272 AUSTIN, TX
Back to MLTX Full portfolio

Position in MLTX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$525,690
-$7,995,343 QoQ
Shares Held
27,000
-94.1% QoQ
Ownership
0.032%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#93
of 172 holders
Holding Since
Mar 2024
9 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in MLTX Over Time

Shares Held

Position Value (USD)

Derivatives in MLTX

reported options exposure · as of Mar 31, 2026
CallValue
$372,800
CallShares
20,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ADAR1 Capital Management, LLC holds $1,760,528,411 across 192 Biotechnology names. MLTX ranks #147 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ABVX
Abivax S.A.
 1,804,703 $240,494,721
2 PTGX
Protagonist Therapeutics, Inc
 960,863 $117,782,586
3 ROIV
Roivant Sciences Ltd.
 3,157,008 $111,726,513
4 IMVT
Immunovant, Inc.
 2,330,716 $89,802,487
5 ZLAB
Zai Lab Ltd
 3,369,034 $64,011,646
6 AGIO
Agios Pharmaceuticals, Inc.
 1,288,053 $47,799,646
7 CRNX
Crinetics Pharmaceuticals, Inc.
 1,222,080 $45,730,233
8 CYTK
Cytokinetics Inc
 457,907 $39,009,097

All Filings in MLTX

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $525,690 27,000
2026-03-31 $372,800 20,000
2026-03-31 $8,521,033 457,137
2025-09-30 $1,086,219 151,495
2025-09-30 $121,890 17,000
2025-06-30 $1,619,620 34,314
2025-03-31 $211,915 5,424
2024-12-31 $943,509 17,424
2024-09-30 $1,182,701 23,457
2024-06-30 $211,056 4,800
2024-03-31 $150,690 3,000